Table 2.
Antimicrobial susceptibility patterns of P. aeruginosa isolated from eyes of different species of animals.
| Drugsa/sample | 1b | 2b | 3b | 4b | 5b | 6b | 7b | 8b | 9b | 10b | 11c | 12d | 13d | 14e | 15f | 16d | S % | R% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENO | S | R | R | S | S | R | R | R | R | R | R | R | S | R | R | R | 25 | 75 |
| CIP | R | S | S | S | S | R | S | S | S | S | R | S | S | S | S | R | 75 | 25 |
| NOR | S | S | S | S | S | R | S | S | S | S | S | R | S | S | S | R | 81.25 | 18.75 |
| GAT | S | S | S | S | S | R | S | S | S | S | R | S | S | S | S | R | 81.25 | 18.75 |
| TOB | R | S | S | S | S | R | S | S | S | S | R | R | S | S | S | R | 68.75 | 31.25 |
| GEN | S | S | S | S | S | R | S | S | S | S | S | R | S | S | S | R | 81.25 | 18.75 |
| AMI | S | S | S | S | S | R | S | S | S | S | S | S | S | S | S | R | 87.5 | 12.5 |
| EST | S | S | S | R | S | R | S | R | S | S | S | R | S | S | R | R | 62.5 | 37.5 |
| NEO | S | R | R | S | S | R | R | R | S | S | S | R | S | S | S | R | 56.25 | 43.75 |
| POL | R | S | S | S | S | R | S | S | S | R | S | S | S | S | S | S | 81.25 | 18.75 |
| IMI | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | 100 | 0 |
a
Drugs: ENO: enrofloxacin; CIP: ciprofloxacin; NOR: norfloxacin; GAT: gatifloxacin; TOB: tobramycin; GEN: gentamicin; AMI: amikacin; EST: streptomycin; NEO: neomycin; POL: polymyxin B; IMI: imipenem. Susceptibilities: (S): susceptible; (R): resistant.
(b)
Strain isolated from dog.
(c)
Strain isolated from cat.
(d)
Strain isolated from horse.
(e)
Strain isolated from penguin.
(f)
Strain isolated from black bear.